Added to YB: 2024-04-22
Pitch date: 2024-04-19
BMRA [bullish]
Biomerica, Inc.
-55.84%
current return
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.
Market Cap
$6.9M
Pitch Price
$5.84
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.80
P/E
-1.11
EV/Sales
0.87
Sector
Health Care Equipment and Supplies
Category
turnaround
Show full summary:
NoName Portfolio Holding: Biomerica, Inc.
BMRA: Diagnostic test co. focused on cancer & IBS. InFoods IBS treatment has big potential. Cheap $13M mkt cap but always losing $, no growth, shares 2x in 7yrs. Stock near lows, maybe new products finally take off this year.
Read full article (1 min)